Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.
Saved in:
| Title: | Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer. |
|---|---|
| Authors: | Wang, Ji1 (AUTHOR), Wang, Xinyang1 (AUTHOR), Chen, Rui1 (AUTHOR), Liang, Mengdi1 (AUTHOR), Li, Minghui1 (AUTHOR), Ma, Ge1 (AUTHOR), Xia, Tiansong1,2 (AUTHOR) xiatsswms@163.com, Wang, Shui1,2 (AUTHOR) shwang@njmu.edu.cn |
| Source: | International Journal of Clinical Oncology. May2022, Vol. 27 Issue 5, p889-898. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13419625 |
|---|---|
| DOI: | 10.1007/s10147-022-02125-9 |